Trial Profile

Candesartan cilexetil +/- enalapril vs enalapril and metoprolol vs placebo in patients with congestive heart failure

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 11 Apr 2012

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Candesartan cilexetil (Primary) ; Enalapril; Metoprolol
Indications Heart failure
Focus Pharmacodynamics; Therapeutic Use
Acronyms RESOLVD
Sponsors AstraZeneca

Most Recent Events

27 Mar 2012 Results assesing the effects of treatment on noradrenaline levels and depression presented at the 61st Annual Scientific Session of the American College of Cardiology.
05 Nov 2010 New trial record.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com